Search - tctmd.com

Displaying 141 - 160 of 225

Sort: Relevancy | Date

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

September 13, 2014

News Industry News

Elixir Medical Announces Schedule of Programs for TCT 2014

September 08, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Industry News

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

June 16, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Industry News

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 14, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

News Industry News

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

February 17, 2014

News Daily News

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Yael L. Maxwell

January 01, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

Advertisement

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

TCT Course Director Outlines Current TAVR Controversies

Michael J. Mack, MD, Becomes First Surgeon to Receive TCT Career Achievement Award

Elixir Medical Announces Schedule of Programs for TCT 2014

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

Edwards Lifesciences Launching SAPIEN XT Valve in the U.S.

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Elixir Medical Corporation to Showcase a Live Case Demonstration of the Breakthrough Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

Tryton Medical Announces Events at EuroPCR 2014 in Paris

Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the SENTINEL™ Cerebral Protection System

PARTNER: Bleeding More Prevalent, Dangerous with Surgery vs. TAVR

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Two Trials to Assess TAVR in Moderate-Risk Patients

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

TCT Leadership Outlines the State of Intervention

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content